rs6265
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Although there was no significant association between BDNF Val66Met polymorphism and TD or AIMS scores across all patients, our results suggest that BDNF Val66Met polymorphism affects severity and, possibly, TD development in Caucasians.
|
24411528 |
2014 |
rs759834365
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Although there was no significant association between BDNF Val66Met polymorphism and TD or AIMS scores across all patients, our results suggest that BDNF Val66Met polymorphism affects severity and, possibly, TD development in Caucasians.
|
24411528 |
2014 |
rs6265
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Serum BDNF levels and genotyping for the BDNF gene Val66Met polymorphism were assessed in Chinese schizophrenic patients with (n = 368) and without (n = 563) TD as well as healthy control subjects (n = 546).
|
22695185 |
2012 |
rs759834365
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Serum BDNF levels and genotyping for the BDNF gene Val66Met polymorphism were assessed in Chinese schizophrenic patients with (n = 368) and without (n = 563) TD as well as healthy control subjects (n = 546).
|
22695185 |
2012 |
rs6265
|
|
|
0.050 |
GeneticVariation |
BEFREE |
This study investigated the relationship between two polymorphisms, val66met in the BDNF coding region and -50T/C in the GSK-3beta promoter, and susceptibility to TD among a matched sample of patients having schizophrenia with TD (n = 83), patients with schizophrenia without TD (n = 78), and normal control subjects (n = 93).
|
19457211 |
2009 |
rs759834365
|
|
|
0.050 |
GeneticVariation |
BEFREE |
This study investigated the relationship between two polymorphisms, val66met in the BDNF coding region and -50T/C in the GSK-3beta promoter, and susceptibility to TD among a matched sample of patients having schizophrenia with TD (n = 83), patients with schizophrenia without TD (n = 78), and normal control subjects (n = 93).
|
19457211 |
2009 |
rs6265
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n=83) and without TD (n=126) who were matched for antipsychotic drug exposure and other relevant variables.
|
18602732 |
2008 |
rs759834365
|
|
|
0.050 |
GeneticVariation |
BEFREE |
Genotyping was performed for the BDNF gene Val66Met SNP in Korean schizophrenic patients with (n=83) and without TD (n=126) who were matched for antipsychotic drug exposure and other relevant variables.
|
18602732 |
2008 |
rs6265
|
|
|
0.050 |
GeneticVariation |
BEFREE |
We concluded that the BDNF val66met genetic polymorphism may exert its effect on the clinically phenotypic variability after TD has occurred.
|
15626824 |
2004 |
rs759834365
|
|
|
0.050 |
GeneticVariation |
BEFREE |
We concluded that the BDNF val66met genetic polymorphism may exert its effect on the clinically phenotypic variability after TD has occurred.
|
15626824 |
2004 |
rs1402139464
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This study investigated the relationship between two polymorphisms, val66met in the BDNF coding region and -50T/C in the GSK-3beta promoter, and susceptibility to TD among a matched sample of patients having schizophrenia with TD (n = 83), patients with schizophrenia without TD (n = 78), and normal control subjects (n = 93).
|
19457211 |
2009 |